直接作用抗病毒治疗时代，丙型肝炎病毒感染与未感染的已故供体肾移植受者的 5 年移植物存活率。
Five-Year Allograft Survival for Recipients of Kidney Transplants From Hepatitis C Virus Infected vs Uninfected Deceased Donors in the Direct-Acting Antiviral Therapy Era.
机构信息
Department of Biostatistics, Epidemiology, and Informatics, Perelman School of Medicine at the University of Pennsylvania, Philadelphia.
Department of Surgery, Hospital of the University of Pennsylvania, Philadelphia.
出版信息
JAMA. 2022 Sep 20;328(11):1102-1104. doi: 10.1001/jama.2022.12868.
Abstract
This cohort study examines the validity of the Kidney Donor Profile Index’s hepatitis C virus (HCV) penalty during the direct-acting antiviral era by comparing 5-year allograft survival between recipients of kidneys from HCV-RNA–positive donors vs HCV-RNA–negative donors.
摘要
本队列研究通过比较 HCV RNA 阳性供体与 HCV RNA 阴性供体的肾脏受者 5 年移植物存活率，考察了直接作用抗病毒时代下 Kidney Donor Profile Index 的丙型肝炎病毒 (HCV) 处罚的有效性。
相似文献
1
Five-Year Allograft Survival for Recipients of Kidney Transplants From Hepatitis C Virus Infected vs Uninfected Deceased Donors in the Direct-Acting Antiviral Therapy Era.直接作用抗病毒治疗时代，丙型肝炎病毒感染与未感染的已故供体肾移植受者的 5 年移植物存活率。
JAMA. 2022 Sep 20;328(11):1102-1104. doi: 10.1001/jama.2022.12868.
2
Short-term outcomes of deceased donor renal transplants of HCV uninfected recipients from HCV seropositive nonviremic donors and viremic donors in the era of direct-acting antivirals.直接作用抗病毒药物时代 HCV 血清阳性非病毒血症供者和病毒血症供者来源的 HCV 阴性受者肾移植的短期结局。
Am J Transplant. 2019 Nov;19(11):3058-3070. doi: 10.1111/ajt.15496. Epub 2019 Aug 7.
3
Transplantation of kidneys from hepatitis C-infected donors to hepatitis C-negative recipients: Single center experience.从丙型肝炎感染供体向丙型肝炎阴性受者移植肾脏：单中心经验。
Am J Transplant. 2019 Nov;19(11):3046-3057. doi: 10.1111/ajt.15530. Epub 2019 Aug 2.
4
A review of kidney transplantation from HCV-viremic donors into HCV-negative recipients.丙型肝炎病毒血症供体至丙型肝炎病毒阴性受体的肾移植综述。
Kidney Int. 2021 Dec;100(6):1190-1198. doi: 10.1016/j.kint.2021.06.034. Epub 2021 Jul 6.
5
Impact of Donor Hepatitis C Virus on Kidney Transplant Outcomes for Hepatitis C-positive Recipients in the Direct-acting Antiviral Era: Time to Revise the Kidney Donor Risk Index?直接作用抗病毒药物时代丙型肝炎病毒供体对丙型肝炎病毒阳性受者肾移植结局的影响：是否需要修订肾脏供体风险指数？
Transplantation. 2020 Jun;104(6):1215-1228. doi: 10.1097/TP.0000000000002949.
6
Transplantation of Kidneys From Hepatitis C Virus-Infected Donors to Hepatitis C Virus-Negative Recipients: One-Year Kidney Allograft Outcomes.丙型肝炎病毒感染供者的肾脏移植到丙型肝炎病毒阴性受者：1 年肾移植结果。
Am J Kidney Dis. 2021 May;77(5):739-747.e1. doi: 10.1053/j.ajkd.2020.10.017. Epub 2020 Dec 14.
7
Utilizing increased risk for disease transmission (IRD) kidneys for pediatric renal transplant recipients.利用具有增加疾病传播风险（IRD）的肾脏为儿科肾移植受者进行移植。
Pediatr Nephrol. 2019 Oct;34(10):1743-1751. doi: 10.1007/s00467-019-04276-w. Epub 2019 Jun 26.
8
Re: Impact of Donor Hepatitis C Virus on Kidney Transplant Outcomes for Hepatitis C-Positive Recipients in the Direct-Acting Antiviral Era: Time to Revise the Kidney Donor Risk Index?关于：在直接抗病毒药物时代，供体丙型肝炎病毒对丙型肝炎病毒阳性受者肾移植结局的影响：是时候修订肾脏供体风险指数了吗？
J Urol. 2020 Dec;204(6):1369. doi: 10.1097/JU.0000000000001277. Epub 2020 Sep 21.
9
Improved Graft Survival After Liver Transplantation for Recipients With Hepatitis C Virus in the Direct-Acting Antiviral Era.直接作用抗病毒药物时代肝移植治疗丙型肝炎病毒感染者的移植物存活率提高。
Liver Transpl. 2019 Apr;25(4):598-609. doi: 10.1002/lt.25424.
10
Use of Organs From Hepatitis C Virus-Positive Donors for Uninfected Recipients: A Potential Cost-Effective Approach to Save Lives?利用丙型肝炎病毒阳性供者的器官用于未感染受者：挽救生命的一种潜在具有成本效益的方法？
Transplantation. 2018 Apr;102(4):664-672. doi: 10.1097/TP.0000000000002033.
引用本文的文献
1
Low prevalence of glomerulonephritis in transplanted kidneys from deceased donors with active hepatitis C virus infection.丙型肝炎病毒感染活跃的已故供体移植肾中肾小球肾炎的低患病率。
Kidney Int. 2025 Aug 22. doi: 10.1016/j.kint.2025.07.026.
2
Hepatitis B Virus NAT Positive Donors in Non-Hepatic Organ Transplant: Quantifying Viral Loads to Optimize Recipient Risk Stratification and Management in the Prevention of Donor-Derived Infection.非肝脏器官移植中乙型肝炎病毒核酸检测阳性供体：量化病毒载量以优化受者风险分层及预防供体源性感染的管理
Clin Transplant. 2025 Jul;39(7):e70236. doi: 10.1111/ctr.70236.
3
Outcomes of High Kidney Donor Profile Index Hepatitis C Nucleic Acid Testing Positive Kidneys are Equivalent to Matched Hepatitis C Nucleic Acid Testing Negative Kidneys.高肾脏捐赠者特征指数丙型肝炎核酸检测呈阳性的肾脏移植结果与匹配的丙型肝炎核酸检测呈阴性的肾脏相当。
Transplant Direct. 2025 Jun 27;11(7):e1827. doi: 10.1097/TXD.0000000000001827. eCollection 2025 Jul.
4
Risk of Cytomegalovirus Viremia Following Transplantation of Hepatitis C-Viremic Donor Kidneys Into Uninfected Recipients: A Multi-Center Retrospective Cohort Study.丙型肝炎病毒血症供体肾脏移植给未感染受体后巨细胞病毒血症的风险：一项多中心回顾性队列研究
Transpl Infect Dis. 2025 Mar 6;27(3):e70011. doi: 10.1111/tid.70011.
5
Prophylactic Treatment of Hepatitis C Virus Infection After Kidney Transplantation with the Combination of Glecaprevir/Pibrentasvir and Sofosbuvir in a Highly Sensitized Hepatitis C Virus-Negative Recipient: A Case Report and Review of the Literature.在高度致敏的丙型肝炎病毒阴性肾移植受者中联合使用glecaprevir/pibrentasvir和索磷布韦对肾移植后丙型肝炎病毒感染进行预防性治疗：一例病例报告及文献综述
Biomedicines. 2025 Feb 14;13(2):472. doi: 10.3390/biomedicines13020472.
6
Twelve-month kidney and liver outcomes of kidney transplantation from Hepatitis C Viremic deceased donors to aviremic recipients.丙型肝炎病毒血症死亡供者向非病毒血症受者进行肾移植的 12 个月的肾脏和肝脏结局。
Transpl Infect Dis. 2024 Feb;26(1):e14213. doi: 10.1111/tid.14213. Epub 2023 Dec 19.
7
Changing spatiotemporal patterns for hepatitis of unspecified aetiology in China, 2004-2021: a population-based surveillance study.2004 - 2021年中国不明病因肝炎的时空模式变化：一项基于人群的监测研究
Front Public Health. 2023 May 5;11:1177965. doi: 10.3389/fpubh.2023.1177965. eCollection 2023.
8
Time to reconsider the role of donor hepatitis C status in the Kidney Donor Risk Index.是时候重新审视供体丙型肝炎状态在肾脏供体风险指数中的作用了。
Am J Transplant. 2023 May;23(5):595-596. doi: 10.1016/j.ajt.2023.02.013. Epub 2023 Feb 10.
9
Early initiation of glecaprevir/pibrentasvir after transplantation of HCV-viremic kidneys into HCV-negative recipients is associated with normalization in the altered inflammatory milieu.肝移植术后 HCV 阳性供肾移植到 HCV 阴性受者后早期应用 glecaprevir/pibrentasvir 治疗与异常炎症环境的正常化有关。
Clin Transplant. 2023 Apr;37(4):e14926. doi: 10.1111/ctr.14926. Epub 2023 Feb 17.
Zotero 插件